209 related articles for article (PubMed ID: 4969837)
1. [Study of the antitubercular activity of new derivatives of aromatic hydrazides. IX. Antitubercular activity in vitro of several new substituted isonicotinoylhydrazides, diphenylsulfonylhydrazides and diphenylsulfonylhydrazidones].
Teitel A; Stroescu V; Demetrescu C; Beneş H; Chiriţă C; Gane P; Steflea D; Chiculescu O
Fiziol Norm Patol; 1967; 13(6):551-60. PubMed ID: 4969837
[No Abstract] [Full Text] [Related]
2. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
[TBL] [Abstract][Full Text] [Related]
3. Experimental data on the antimicrobial activity of Isoprodian (PTH).
Urbanczik R
Scand J Respir Dis Suppl; 1978; 102():58-9. PubMed ID: 98838
[No Abstract] [Full Text] [Related]
4. [Derivatives of thiourea and their antitubercular activity].
Riccieri FM; Porcelli GA; Castellani Pastoris M
Farmaco Sci; 1967 Feb; 22(2):114-20. PubMed ID: 4962184
[No Abstract] [Full Text] [Related]
5. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
6. [Derivatives of 2-thion-3-isonicotinoylamino-thiazolid-4-one with tuberculostatic activity].
Dănilă G; Radu C
Rev Med Chir Soc Med Nat Iasi; 1978; 82(1):127-30. PubMed ID: 97745
[No Abstract] [Full Text] [Related]
7. [Study of the tuberculostatic activity of some azomethines and isonicotinyl hydrazones in vitro].
Aptekar' MD; Korol' II; Trailina EP; Savich IA
Mikrobiol Zh; 1974; 36(4):502-6. PubMed ID: 4219445
[No Abstract] [Full Text] [Related]
8. In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: part 14.
Maccari R; Ottanà R; Vigorita MG
Bioorg Med Chem Lett; 2005 May; 15(10):2509-13. PubMed ID: 15863306
[TBL] [Abstract][Full Text] [Related]
9. [Action of protionamide on tuberculosis mycobacteria in vitro].
Kalabukha AV; Klimenko MT
Mikrobiol Zh; 1972; 34(6):778-82. PubMed ID: 4199956
[No Abstract] [Full Text] [Related]
10. [Comparison between antituberculous activity of alpha-ethyl-thioisonicotinamide (1314 TH) and alpha-N-propylthioisonicotinamide (1321 TH) in vitro].
Tamura M; Takano S
Kekkaku; 1971 May; 46(5):137-52. PubMed ID: 4996120
[No Abstract] [Full Text] [Related]
11. [Experimental studies on the isonicotinic acid hypothesis of the mechanism of action of isoniazid].
Seydel JK; Wempe E; Nestler HJ
Arzneimittelforschung; 1968 Mar; 18(3):362-7. PubMed ID: 4971942
[No Abstract] [Full Text] [Related]
12. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
Lourenço MC; Ferreira Mde L; de Souza MV; Peralta MA; Vasconcelos TR; Henriques Md
Eur J Med Chem; 2008 Jun; 43(6):1344-7. PubMed ID: 17923172
[TBL] [Abstract][Full Text] [Related]
13. [Antitubercular agents. X. The action of derivatives of 3-substituted 2 pyrazinecarboxylic acid].
Novácek L; Celadník M; Palát K; Kubala E
Cesk Farm; 1969 Oct; 18(8):385-7. PubMed ID: 4984000
[No Abstract] [Full Text] [Related]
14. [Antitubercular agents. 45. Antimycobacterial thiohydrazide].
Waisser K; Odlerová Z; Houngbedji N; Thiel W; Mayer R
Zentralbl Mikrobiol; 1989; 144(5):355-7. PubMed ID: 2515678
[TBL] [Abstract][Full Text] [Related]
15. [On the tuberculostatic effect of some new isonicotinoylhydrazide derivatives].
Gheorghiu P; Stroescu V; Demetrescu C; Benes H; Gane P; Steflea D; Moldoveanu O
Pharmazie; 1966 Feb; 21(2):115-6. PubMed ID: 4963959
[No Abstract] [Full Text] [Related]
16. Synthesis, characterization and in-vitro antitubercular activity of isoniazid-gelatin conjugate.
Cassano R; Trombino S; Ferrarelli T; Cavalcanti P; Giraldi C; Lai F; Loy G; Picci N
J Pharm Pharmacol; 2012 May; 64(5):712-8. PubMed ID: 22471367
[TBL] [Abstract][Full Text] [Related]
17. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
Steinbrück PW
Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
[No Abstract] [Full Text] [Related]
18. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
19. Isoniazid activity is terminated by bacterial persistence.
Mitchison DA; Jindani A; Davies GR; Sirgel F
J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
[No Abstract] [Full Text] [Related]
20. Studies of early bactericidal activity: new insights into isoniazid pharmacokinetics.
Gillespie SH
Clin Infect Dis; 2004 Nov; 39(10):1431-2. PubMed ID: 15546076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
